Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong · Delayed Price · Currency is HKD 34.16
+0.96 (2.89%)
Sep 11, 2026, 3:58 PM HKT
HKG:1501 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,200 | 1,065 | 851.95 | 752.84 | 585.88 | 464.68 |
Revenue Growth | 12.67% | 25.06% | 13.17% | 28.50% | 26.08% | 29.64% |
Gross Profit Gross Profit Growth | 730.51 | 636.79 | 537.66 | 438.07 | 332.49 | 275.75 |
Operating Income Operating Income Growth | 311.55 | 258.29 | 212.02 | 161.99 | 129.34 | 144.64 |
Net Income Net Income Growth | 218.28 | 206.23 | 180.92 | 151.88 | 130.15 | 142.96 |
Earnings Per Share EPS Growth | 1.22 | 1.26 | 1.10 | 0.92 | 0.78 | 0.86 |
EPS Growth | -2.99% | 14.17% | 20.10% | 17.49% | -9.38% | 17.81% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cardiovascular Interventional Business Cardiovascular Interventional Business Growth | 885.1 | 876.93 | 771.93 | 641.32 | 497.05 | 411.18 |
ALL Others ALL Others Growth | 448.72 | 304.17 | 163.57 | 160.24 | 133.26 | 81.73 |
Elimination of Inter-Segment Elimination of Inter-Segment Growth | -133.37 | -115.63 | -83.55 | -48.73 | -44.43 | -28.24 |
Total Total Growth | 1,200 | 1,065 | 851.95 | 752.84 | 585.88 | 464.68 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,322 | 650.81 | 551.95 | 434.4 | 528.27 | 640.55 |
Total Debt Total Debt Growth | 716.38 | 715.96 | 243.69 | 94.78 | 48.83 | 13.4 |
Net Cash (Debt) Net Cash Growth | 605.65 | -65.14 | 308.27 | 339.62 | 479.44 | 627.15 |
Net Cash Growth | - | - | -9.23% | -29.16% | -23.55% | -33.27% |
Net Cash Per Share Net Cash Per Share Growth | 3.22 | -0.38 | 1.81 | 1.99 | 2.84 | 3.76 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 348.11 | 225.54 | 178.15 | 180.46 | 72.76 |
Capital Expenditures CapEx Growth | - | -64.48 | -125.74 | -168.84 | -243.21 | -277.83 |
Free Cash Flow Free Cash Flow Growth | - | 283.63 | 99.8 | 9.31 | -62.75 | -205.07 |
Free Cash Flow Growth | - | 184.18% | 972.35% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 60.85% | 59.77% | 63.11% | 58.19% | 56.75% | 59.34% |
Operating Margin | 25.95% | 24.24% | 24.89% | 21.52% | 22.08% | 31.13% |
Pretax Margin | 23.52% | 24.24% | 25.05% | 23.26% | 24.66% | 33.51% |
Profit Margin | 18.18% | 19.36% | 21.24% | 20.18% | 22.21% | 30.77% |
FCF Margin | - | 26.62% | 11.71% | 1.24% | -10.71% | -44.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.260 | 0.230 | - | 0.270 | 0.240 | 0.260 |
Dividend Per Share Growth | 0% | - | - | 12.50% | -7.69% | -8.77% |
Dividend Yield | 0.73% | 0.86% | - | 1.06% | 0.97% | 1.46% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.25 | 22.89 | 26.47 | 29.23 | 32.83 | 21.76 |
Forward PE | - | 23.03 | 18.88 | 20.44 | 20.89 | 23.81 |
P/FCF Ratio | - | 16.64 | 47.97 | 476.97 | - | - |
PS Ratio | 5.20 | 4.43 | 5.62 | 5.90 | 7.29 | 6.69 |